Your browser doesn't support javascript.
loading
[The efficacy and safety of CLAG-M/I regimen for relapsed or refractory acute myeloid leukemia in children].
Li, H M; Wang, Y P; Huang, J; Xue, Y; Sun, X Y; Fang, Y J.
Affiliation
  • Li HM; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210003, China.
  • Wang YP; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210003, China.
  • Huang J; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210003, China.
  • Xue Y; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210003, China.
  • Sun XY; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210003, China.
  • Fang YJ; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210003, China.
Zhonghua Xue Ye Xue Za Zhi ; 43(4): 342-345, 2022 04 14.
Article in Zh | MEDLINE | ID: mdl-35680635
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Child / Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Child / Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China